147 related articles for article (PubMed ID: 21636674)
1. MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
Permuth-Wey J; Chen Z; Tsai YY; Lin HY; Chen YA; Barnholtz-Sloan J; Birrer MJ; Chanock SJ; Cramer DW; Cunningham JM; Fenstermacher D; Fridley BL; Garcia-Closas M; Gayther SA; Gentry-Maharaj A; Gonzalez-Bosquet J; Iversen E; Jim H; McLaughlin J; Menon U; Narod SA; Phelan CM; Ramus SJ; Risch H; Song H; Sutphen R; Terry KL; Tyrer J; Vierkant RA; Wentzensen N; Lancaster JM; Cheng JQ; Berchuck A; Pharoah PD; Schildkraut JM; Goode EL; Sellers TA;
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1793-7. PubMed ID: 21636674
[TBL] [Abstract][Full Text] [Related]
2. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
Permuth-Wey J; Kim D; Tsai YY; Lin HY; Chen YA; Barnholtz-Sloan J; Birrer MJ; Bloom G; Chanock SJ; Chen Z; Cramer DW; Cunningham JM; Dagne G; Ebbert-Syfrett J; Fenstermacher D; Fridley BL; Garcia-Closas M; Gayther SA; Ge W; Gentry-Maharaj A; Gonzalez-Bosquet J; Goode EL; Iversen E; Jim H; Kong W; McLaughlin J; Menon U; Monteiro AN; Narod SA; Pharoah PD; Phelan CM; Qu X; Ramus SJ; Risch H; Schildkraut JM; Song H; Stockwell H; Sutphen R; Terry KL; Tyrer J; Vierkant RA; Wentzensen N; Lancaster JM; Cheng JQ; Sellers TA;
Cancer Res; 2011 Jun; 71(11):3896-903. PubMed ID: 21482675
[TBL] [Abstract][Full Text] [Related]
3. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
Chornokur G; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Amankwah EK; Qu X; Tsai YY; Jim HS; Chen Z; Chen AY; Permuth-Wey J; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kelemen LE; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Hasmad HN; Berchuck A; ; ; Iversen ES; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
PLoS One; 2015; 10(6):e0128106. PubMed ID: 26091520
[TBL] [Abstract][Full Text] [Related]
4. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
Pharoah PD; Palmieri RT; Ramus SJ; Gayther SA; Andrulis IL; Anton-Culver H; Antonenkova N; Antoniou AC; Goldgar D; ; Beattie MS; Beckmann MW; Birrer MJ; Bogdanova N; Bolton KL; Brewster W; Brooks-Wilson A; Brown R; Butzow R; Caldes T; Caligo MA; Campbell I; Chang-Claude J; Chen YA; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Despierre E; Doherty JA; Dörk T; Dürst M; Eccles DM; Ekici AB; Easton D; ; Fasching PA; de Fazio A; Fenstermacher DA; Flanagan JM; Fridley BL; Friedman E; Gao B; Sinilnikova O; ; Gentry-Maharaj A; Godwin AK; Goode EL; Goodman MT; Gross J; Hansen TV; Harnett P; Rookus M; ; Heikkinen T; Hein R; Høgdall C; Høgdall E; Iversen ES; Jakubowska A; Johnatty SE; Karlan BY; Kauff ND; Kaye SB; Chenevix-Trench G; ; Kelemen LE; Kiemeney LA; Kjaer SK; Lambrechts D; Lapolla JP; Lázaro C; Le ND; Leminen A; Leunen K; Levine DA; Lu Y; Lundvall L; Macgregor S; Marees T; Massuger LF; McLaughlin JR; Menon U; Montagna M; Moysich KB; Narod SA; Nathanson KL; Nedergaard L; Ness RB; Nevanlinna H; Nickels S; Osorio A; Paul J; Pearce CL; Phelan CM; Pike MC; Radice P; Rossing MA; Schildkraut JM; Sellers TA; Singer CF; Song H; Stram DO; Sutphen R; Lindblom A; ; Terry KL; Tsai YY; van Altena AM; Vergote I; Vierkant RA; Vitonis AF; Walsh C; Wang-Gohrke S; Wappenschmidt B; Wu AH; Ziogas A; Berchuck A; Risch HA;
Clin Cancer Res; 2011 Jun; 17(11):3742-50. PubMed ID: 21385923
[TBL] [Abstract][Full Text] [Related]
5. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
Lawrenson K; Iversen ES; Tyrer J; Weber RP; Concannon P; Hazelett DJ; Li Q; Marks JR; Berchuck A; Lee JM; Aben KK; Anton-Culver H; Antonenkova N; ; ; Bandera EV; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chenevix-Trench G; Chen A; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Plisiecka-Halasa J; Dennis J; Dicks E; Doherty JA; Dörk T; du Bois A; Eccles D; Easton DT; Edwards RP; Eilber U; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Gronwald J; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Jakubowska A; Paul J; Jensen A; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Lambrechts D; Lambrechts S; Le ND; Lee AW; Cannioto R; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Nevanlinna H; McNeish I; Menon U; Modugno F; Moysich KB; Narod SA; Nedergaard L; Ness RB; Noor Azmi MA; Odunsi K; Olson SH; Orlow I; Orsulic S; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Phelan CM; Pike MC; Poole EM; Ramus SJ; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Budzilowska A; Sellers TA; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Sucheston L; Tangen IL; Teo SH; Terry KL; Thompson PJ; Timorek A; Tworoger SS; Van Nieuwenhuysen E; Vergote I; Vierkant RA; Wang-Gohrke S; Walsh C; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Woo YL; Wu X; Wu AH; Yang H; Zheng W; Ziogas A; Coetzee GA; Freedman ML; Monteiro AN; Moes-Sosnowska J; Kupryjanczyk J; Pharoah PD; Gayther SA; Schildkraut JM
Carcinogenesis; 2015 Nov; 36(11):1341-53. PubMed ID: 26424751
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.
Amankwah EK; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Chornokur G; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chen Z; Chen YA; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Jim H; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston-Campbell L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Kelemen LE; Berchuck A; ; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
Genet Epidemiol; 2015 Dec; 39(8):689-97. PubMed ID: 26399219
[TBL] [Abstract][Full Text] [Related]
7. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.
Reid BM; Permuth JB; Chen YA; Teer JK; Monteiro AN; Chen Z; Tyrer J; Berchuck A; Chenevix-Trench G; Doherty JA; Goode EL; Iverson ES; Lawrenson K; Pearce CL; Pharoah PD; Phelan CM; Ramus SJ; Rossing MA; Schildkraut JM; Cheng JQ; Gayther SA; Sellers TA; ; ;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):116-125. PubMed ID: 28035019
[TBL] [Abstract][Full Text] [Related]
8. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
Permuth-Wey J; Fulp WJ; Reid BM; Chen Z; Georgeades C; Cheng JQ; Magliocco A; Chen DT; Lancaster JM
Int J Cancer; 2016 Feb; 138(3):612-9. PubMed ID: 26264211
[TBL] [Abstract][Full Text] [Related]
9. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Permuth-Wey J; Lawrenson K; Shen HC; Velkova A; Tyrer JP; Chen Z; Lin HY; Chen YA; Tsai YY; Qu X; Ramus SJ; Karevan R; Lee J; Lee N; Larson MC; Aben KK; Anton-Culver H; Antonenkova N; Antoniou AC; Armasu SM; ; ; Bacot F; Baglietto L; Bandera EV; Barnholtz-Sloan J; Beckmann MW; Birrer MJ; Bloom G; Bogdanova N; Brinton LA; Brooks-Wilson A; Brown R; Butzow R; Cai Q; Campbell I; Chang-Claude J; Chanock S; Chenevix-Trench G; Cheng JQ; Cicek MS; Coetzee GA; ; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Dansonka-Mieszkowska A; Despierre E; Doherty JA; Dörk T; du Bois A; Dürst M; Easton DF; Eccles D; Edwards R; Ekici AB; Fasching PA; Fenstermacher DA; Flanagan JM; Garcia-Closas M; Gentry-Maharaj A; Giles GG; Glasspool RM; Gonzalez-Bosquet J; Goodman MT; Gore M; Górski B; Gronwald J; Hall P; Halle MK; Harter P; Heitz F; Hillemanns P; Hoatlin M; Høgdall CK; Høgdall E; Hosono S; Jakubowska A; Jensen A; Jim H; Kalli KR; Karlan BY; Kaye SB; Kelemen LE; Kiemeney LA; Kikkawa F; Konecny GE; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Lancaster JM; Le ND; Leminen A; Levine DA; Liang D; Lim BK; Lin J; Lissowska J; Lu KH; Lubiński J; Lurie G; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Menon U; Modugno F; Moysich KB; Nakanishi T; Narod SA; Nedergaard L; Ness RB; Nevanlinna H; Nickels S; Noushmehr H; Odunsi K; Olson SH; Orlow I; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Raska P; Renner SP; Risch HA; Rodriguez-Rodriguez L; Rossing MA; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schwaab I; Severi G; Shridhar V; Shu XO; Shvetsov YB; Sieh W; Song H; Southey MC; Spiewankiewicz B; Stram D; Sutphen R; Teo SH; Terry KL; Tessier DC; Thompson PJ; Tworoger SS; van Altena AM; Vergote I; Vierkant RA; Vincent D; Vitonis AF; Wang-Gohrke S; Palmieri Weber R; Wentzensen N; Whittemore AS; Wik E; Wilkens LR; Winterhoff B; Woo YL; Wu AH; Xiang YB; Yang HP; Zheng W; Ziogas A; Zulkifli F; Phelan CM; Iversen E; Schildkraut JM; Berchuck A; Fridley BL; Goode EL; Pharoah PD; Monteiro AN; Sellers TA; Gayther SA
Nat Commun; 2013; 4():1627. PubMed ID: 23535648
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
Grant DJ; Hoyo C; Akushevich L; Iversen ES; Whitaker R; Marks J; Berchuck A; Schildkraut JM
Gynecol Oncol; 2013 Apr; 129(1):173-8. PubMed ID: 23262379
[TBL] [Abstract][Full Text] [Related]
11. A targeted genetic association study of epithelial ovarian cancer susceptibility.
Earp M; Winham SJ; Larson N; Permuth JB; Sicotte H; Chien J; Anton-Culver H; Bandera EV; Berchuck A; Cook LS; Cramer D; Doherty JA; Goodman MT; Levine DA; Monteiro AN; Ness RB; Pearce CL; Rossing MA; Tworoger SS; Wentzensen N; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Cunningham JM; Edwards RP; Fogarty ZC; Iversen ES; Kraft P; Larson MC; Le ND; Lin HY; Lissowska J; Modugno F; Moysich KB; Olson SH; Pike MC; Poole EM; Rider DN; Terry KL; Thompson PJ; van den Berg D; Vierkant RA; Vitonis AF; Wilkens LR; Wu AH; Yang HP; Ziogas A; Phelan CM; Schildkraut JM; Chen YA; Sellers TA; Fridley BL; Goode EL
Oncotarget; 2016 Feb; 7(7):7381-9. PubMed ID: 26848776
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.
Liang D; Meyer L; Chang DW; Lin J; Pu X; Ye Y; Gu J; Wu X; Lu K
Cancer Res; 2010 Dec; 70(23):9765-76. PubMed ID: 21118967
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
14. ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
Johnatty SE; Beesley J; Gao B; Chen X; Lu Y; Law MH; Henderson MJ; Russell AJ; Hedditch EL; Emmanuel C; Fereday S; Webb PM; ; Goode EL; Vierkant RA; Fridley BL; Cunningham JM; Fasching PA; Beckmann MW; Ekici AB; Hogdall E; Kjaer SK; Jensen A; Hogdall C; Brown R; Paul J; Lambrechts S; Despierre E; Vergote I; Lester J; Karlan BY; Heitz F; du Bois A; Harter P; Schwaab I; Bean Y; Pejovic T; Levine DA; Goodman MT; Camey ME; Thompson PJ; Lurie G; Shildkraut J; Berchuck A; Terry KL; Cramer DW; Norris MD; Haber M; MacGregor S; deFazio A; Chenevix-Trench G
Gynecol Oncol; 2013 Oct; 131(1):8-14. PubMed ID: 23917080
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.
Johnatty SE; Tyrer JP; Kar S; Beesley J; Lu Y; Gao B; Fasching PA; Hein A; Ekici AB; Beckmann MW; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Lambrechts S; Rossing MA; Doherty JA; Chang-Claude J; Modugno F; Ness RB; Moysich KB; Levine DA; Kiemeney LA; Massuger LF; Gronwald J; Lubiński J; Jakubowska A; Cybulski C; Brinton L; Lissowska J; Wentzensen N; Song H; Rhenius V; Campbell I; Eccles D; Sieh W; Whittemore AS; McGuire V; Rothstein JH; Sutphen R; Anton-Culver H; Ziogas A; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Pearce CL; Pike MC; Stram DO; Wu AH; Kupryjanczyk J; Dansonka-Mieszkowska A; Rzepecka IK; Spiewankiewicz B; Goodman MT; Wilkens LR; Carney ME; Thompson PJ; Heitz F; du Bois A; Schwaab I; Harter P; Pisterer J; Hillemanns P; ; Karlan BY; Walsh C; Lester J; Orsulic S; Winham SJ; Earp M; Larson MC; Fogarty ZC; Høgdall E; Jensen A; Kjaer SK; Fridley BL; Cunningham JM; Vierkant RA; Schildkraut JM; Iversen ES; Terry KL; Cramer DW; Bandera EV; Orlow I; Pejovic T; Bean Y; Høgdall C; Lundvall L; McNeish I; Paul J; Carty K; Siddiqui N; Glasspool R; Sellers T; Kennedy C; Chiew YE; Berchuck A; MacGregor S; Pharoah PD; Goode EL; deFazio A; Webb PM; Chenevix-Trench G;
Clin Cancer Res; 2015 Dec; 21(23):5264-76. PubMed ID: 26152742
[TBL] [Abstract][Full Text] [Related]
16. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
Hampras SS; Sucheston-Campbell LE; Cannioto R; Chang-Claude J; Modugno F; Dörk T; Hillemanns P; Preus L; Knutson KL; Wallace PK; Hong CC; Friel G; Davis W; Nesline M; Pearce CL; Kelemen LE; Goodman MT; Bandera EV; Terry KL; Schoof N; Eng KH; Clay A; Singh PK; Joseph JM; Aben KK; Anton-Culver H; Antonenkova N; Baker H; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Cook LS; Cramer DW; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Despierre E; Dicks E; Doherty JA; du Bois A; Dürst M; Easton D; Eccles D; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hogdall C; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kellar M; Kelley JL; Kiemeney LA; Klapdor R; Kolomeyevskaya N; Krakstad C; Kjaer SK; Kruszka B; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Liu S; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Moes-Sosnowska J; Narod SA; Nedergaard L; Nevanlinna H; Nickels S; Olson SH; Orlow I; Weber RP; Paul J; Pejovic T; Pelttari LM; Perkins B; Permuth-Wey J; Pike MC; Plisiecka-Halasa J; Poole EM; Risch HA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schmitt K; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Tangen IL; Teo SH; Thompson PJ; Timorek A; Tsai YY; Tworoger SS; Tyrer J; van Altena AM; Vergote I; Vierkant RA; Walsh C; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Gayther SA; Ramus SJ; Sellers TA; Schildkraut JM; Phelan CM; Berchuck A; Chenevix-Trench G; Cunningham JM; Pharoah PP; Ness RB; Odunsi K; Goode EL; Moysich KB
Oncotarget; 2016 Oct; 7(43):69097-69110. PubMed ID: 27533245
[TBL] [Abstract][Full Text] [Related]
17. A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer.
Wang C; Guo Z; Wu C; Li Y; Kang S
Cancer Genet; 2012; 205(7-8):373-6. PubMed ID: 22867998
[TBL] [Abstract][Full Text] [Related]
18. [Association between single nucleotide polymorphism of BARD1 gene and BRCA1 gene mutation in epithelial ovarian cancer].
Liu WL; Zhao JZ; Wang ZZ; Dong B; Hou YY; Wu XX; Guo YJ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):403-410. PubMed ID: 28647964
[No Abstract] [Full Text] [Related]
19. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
Earp MA; Kelemen LE; Magliocco AM; Swenerton KD; Chenevix-Trench G; ; ; Lu Y; Hein A; Ekici AB; Beckmann MW; Fasching PA; Lambrechts D; Despierre E; Vergote I; Lambrechts S; Doherty JA; Rossing MA; Chang-Claude J; Rudolph A; Friel G; Moysich KB; Odunsi K; Sucheston-Campbell L; Lurie G; Goodman MT; Carney ME; Thompson PJ; Runnebaum IB; Dürst M; Hillemanns P; Dörk T; Antonenkova N; Bogdanova N; Leminen A; Nevanlinna H; Pelttari LM; Butzow R; Bunker CH; Modugno F; Edwards RP; Ness RB; du Bois A; Heitz F; Schwaab I; Harter P; Karlan BY; Walsh C; Lester J; Jensen A; Kjær SK; Høgdall CK; Høgdall E; Lundvall L; Sellers TA; Fridley BL; Goode EL; Cunningham JM; Vierkant RA; Giles GG; Baglietto L; Severi G; Southey MC; Liang D; Wu X; Lu K; Hildebrandt MA; Levine DA; Bisogna M; Schildkraut JM; Iversen ES; Weber RP; Berchuck A; Cramer DW; Terry KL; Poole EM; Tworoger SS; Bandera EV; Chandran U; Orlow I; Olson SH; Wik E; Salvesen HB; Bjorge L; Halle MK; van Altena AM; Aben KK; Kiemeney LA; Massuger LF; Pejovic T; Bean YT; Cybulski C; Gronwald J; Lubinski J; Wentzensen N; Brinton LA; Lissowska J; Garcia-Closas M; Dicks E; Dennis J; Easton DF; Song H; Tyrer JP; Pharoah PD; Eccles D; Campbell IG; Whittemore AS; McGuire V; Sieh W; Rothstein JH; Flanagan JM; Paul J; Brown R; Phelan CM; Risch HA; McLaughlin JR; Narod SA; Ziogas A; Anton-Culver H; Gentry-Maharaj A; Menon U; Gayther SA; Ramus SJ; Wu AH; Pearce CL; Pike MC; Dansonka-Mieszkowska A; Rzepecka IK; Szafron LM; Kupryjanczyk J; Cook LS; Le ND; Brooks-Wilson A;
Hum Genet; 2014 May; 133(5):481-97. PubMed ID: 24190013
[TBL] [Abstract][Full Text] [Related]
20. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.
Permuth JB; Pirie A; Ann Chen Y; Lin HY; Reid BM; Chen Z; Monteiro A; Dennis J; Mendoza-Fandino G; ; ; Anton-Culver H; Bandera EV; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Chenevix-Trench G; Cook LS; Cramer DW; Cunningham JM; Cybulski C; D'Aloisio AA; Anne Doherty J; Earp M; Edwards RP; Fridley BL; Gayther SA; Gentry-Maharaj A; Goodman MT; Gronwald J; Hogdall E; Iversen ES; Jakubowska A; Jensen A; Karlan BY; Kelemen LE; Kjaer SK; Kraft P; Le ND; Levine DA; Lissowska J; Lubinski J; Matsuo K; Menon U; Modugno R; Moysich KB; Nakanishi T; Ness RB; Olson S; Orlow I; Pearce CL; Pejovic T; Poole EM; Ramus SJ; Anne Rossing M; Sandler DP; Shu XO; Song H; Taylor JA; Teo SH; Terry KL; Thompson PJ; Tworoger SS; Webb PM; Wentzensen N; Wilkens LR; Winham S; Woo YL; Wu AH; Yang H; Zheng W; Ziogas A; Phelan CM; Schildkraut JM; Berchuck A; Goode EL; Pharoah PD; Sellers TA;
Hum Mol Genet; 2016 Aug; 25(16):3600-3612. PubMed ID: 27378695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
